MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA Study

Magda Tsolaki, Vasileios Papaliagkas, Giovanni Frisoni, Roy Jones, Jacques Touchon, Luiza Spiru, Bruno Vellas, Frans Verhey, Bengt Winblad, Pieter Jelle Visser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1407-1413
JournalCurrent Alzheimer Research
Volume13
Issue number12
DOIs
Publication statusPublished - 2016

Keywords

  • Alzheimer's disease
  • anticholinergic drugs
  • co-morbidity
  • medication
  • mild cognitive impairment

Cite this

Tsolaki, M., Papaliagkas, V., Frisoni, G., Jones, R., Touchon, J., Spiru, L., Vellas, B., Verhey, F., Winblad, B., & Visser, P. J. (2016). MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA Study. Current Alzheimer Research, 13(12), 1407-1413. https://doi.org/10.2174/1567205013666160603002704